Allianz Asset Management Gmb H Blueprint Medicines Corp Transaction History
Allianz Asset Management Gmb H
- $69.7 Billion
- Q3 2024
A detailed history of Allianz Asset Management Gmb H transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 7,200 shares of BPMC stock, worth $660,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,200
Previous 5,800
24.14%
Holding current value
$660,816
Previous $625,000
6.4%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$610 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$494 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$364 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$254 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.48B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...